Schonfeld Strategic Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,669
| Closed | -$417K | – | 2207 |
|
|
2025
Q1 | $417K | Buy |
10,669
+6,758
| +173% | +$264K | ﹤0.01% | 1536 |
|
|
2024
Q4 | $212K | Sell |
3,911
-82,864
| -95% | -$4.49M | ﹤0.01% | 1681 |
|
|
2024
Q3 | $4.38M | Sell |
86,775
-29,663
| -25% | -$1.5M | 0.03% | 494 |
|
|
2024
Q2 | $5.12M | Sell |
116,438
-27,012
| -19% | -$1.19M | 0.03% | 472 |
|
|
2024
Q1 | $7.21M | Sell |
143,450
-16,950
| -11% | -$851K | 0.05% | 427 |
|
|
2023
Q4 | $9.69M | Sell |
160,400
-180,300
| -53% | -$10.9M | 0.06% | 326 |
|
|
2023
Q3 | $19.4M | Buy |
340,700
+222,740
| +189% | +$12.7M | 0.15% | 171 |
|
|
2023
Q2 | $6.02M | Buy |
117,960
+80,760
| +217% | +$4.12M | 0.05% | 446 |
|
|
2023
Q1 | $796K | Buy |
+37,200
| New | +$796K | 0.01% | 1015 |
|
|
2022
Q1 | – | Sell |
-50,106
| Closed | -$496K | – | 2580 |
|
|
2021
Q4 | $496K | Buy |
+50,106
| New | +$496K | ﹤0.01% | 1201 |
|